← Oncology Approval Tracker

FDA DECISION ·

Phesgo

pertuzumab + trastuzumab + hyaluronidase-zzxf · Genentech

FDA approvalNew formulationBreast cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

With chemotherapy before surgery for HER2-positive locally advanced, inflammatory or early breast cancer over 2 cm or node positive; with chemotherapy after surgery for high-risk HER2-positive early disease; and with docetaxel for HER2-positive metastatic disease without prior HER2-directed treatment or chemotherapy in the metastatic setting.

LAMPGEN ANALYSIS

Why it matters

Combined two HER2-directed antibodies into one subcutaneous administration.

What research teams should watch

Train on loading and maintenance doses and preserve cardiac monitoring and post-injection observation.

PRIMARY RECORDS

Sources